Expression of active recombinant human tissue-type plasminogen activator by using in vivo polyhydroxybutyrate granule display

Applied and Environmental Microbiology

Volumn 76, Issue 21, 2010, Pages 7226-7230

  Geng, Yanping ^a   Wang, Shengjun ^a   Qi, Qingsheng ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVITY ASSAYS; AFFINITY TAG; CLEAVAGE SITES; COMPLEX CONFORMATION; DISULFIDE BONDS; EUKARYOTIC PROTEINS; EXPRESSION IN ESCHERICHIA COLI; HUMAN TISSUES; IMMUNOBLOT ANALYSIS; IN-VIVO; INCLUSION BODIES; POLYHYDROXYBUTYRATE; SODIUM DODECYL SULFATE-POLYACRYLAMIDE GEL ELECTROPHORESIS; SURFACE DISPLAYS; TISSUE PLASMINOGEN ACTIVATOR (TPA); TRUNCATED VERSIONS;

ELECTROPHORESIS; ESCHERICHIA COLI; SODIUM; SODIUM SULFATE; TISSUE;

GRANULATION;

DIAGNOSTIC AGENT; HYBRID PROTEIN; HYDROXYBUTYRIC ACID; PHASIN; PLANT LECTIN; POLYESTER; TISSUE PLASMINOGEN ACTIVATOR;

COLIFORM BACTERIUM; ELECTROKINESIS; GENE EXPRESSION; PROTEIN; RECOMBINATION;

ARTICLE; BIOSYNTHESIS; ESCHERICHIA COLI; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; POLYACRYLAMIDE GEL ELECTROPHORESIS; WESTERN BLOTTING;

BLOTTING, WESTERN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESCHERICHIA COLI; GENE EXPRESSION; HUMANS; HYDROXYBUTYRATES; PLANT LECTINS; POLYESTERS; RECOMBINANT FUSION PROTEINS; TISSUE PLASMINOGEN ACTIVATOR;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; EUKARYOTA;

EID: 78149440020     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.01543-10     Document Type: Article

References (28)

1. Anderson, A. J., and E. A. Dawes. 1990. Occurrence, metabolism, metabolic role, and industrial uses of bacterial polyhydroxyalkanoates. Microbiol. Rev. 54:450-472.
2. Backstrom, B. T., J. A. Brockelbank, and B. H. Rehm. 2007. Recombinant Escherichia coli produces tailor-made biopolyester granules for applications in fluorescence activated cell sorting: Functional display of the mouse interleukin- 2 and myelin oligodendrocyte glycoprotein. BMC Biotechnol. 7:3.
3. Baneyx, F., and M. Mujacic. 2004. Recombinant protein folding and misfolding in Escherichia coli. Nat. Biotechnol. 22:1399-1408.
4. Banki, M. R., T. U. Gerngross, and D. W. Wood. 2005. Novel and economical purification of recombinant proteins: Intein-mediated protein purification using in vivo polyhydroxybutyrate (PHB) matrix association. Protein Sci. 14:1387-1395.
5. Barnard, G. C., J. D. McCool, D. W. Wood, and T. U. Gerngross. 2005. Integrated recombinant protein expression and purification platform based on Ralstonia eutropha. Appl. Environ. Microbiol. 71:5735-5742.
6. Bessette, P. H., F. Aslund, J. Beckwith, and G. Georgiou. 1999. Efficient folding of proteins with multiple disulfide bonds in the Escherichia coli cytoplasm. Proc. Natl. Acad. Sci. U. S. A. 96:13703-13708.
7. Dawes, E. A. 1988. Polyhydroxybutyrate: An intriguing biopolymer. Biosci. Rep. 8:537-547.
8. Granelli-Piperno, A., and E. Reich. 1978. A study of proteases and proteaseinhibitor complexes in biological fluids. J. Exp. Med. 148:223-234.
9. Kang, Z., Y. P. Geng, Y. Z. Xia, J. H. Kang, and Q. S. Qi. 2009. Engineering Escherichia coli for an efficient aerobic fermentation platform. J. Biotechnol. 144:58-63.
10. Kang, Z., Q. Wang, H. Zhang, and Q. Qi. 2008. Construction of a stressinduced system in Escherichia coli for efficient polyhydroxyalkanoates production. Appl. Microbiol. Biotechnol. 79:203-208.
11. Kim, J. Y., E. A. Fogarty, F. J. Lu, H. Zhu, G. D. Wheelock, L. A. Henderson, and M. P. DeLisa. 2005. Twin-arginine translocation of active human tissue plasminogen activator in Escherichia coli. Appl. Environ. Microbiol. 71: 8451-8459.
12. Kohnert, U., R. Rudolph, J. H. Verheijen, E. J. Weening-Verhoeff, A. Stern, U. Opitz, U. Martin, H. Lill, H. Prinz, M. Lechner, et al. 1992. Biochemical properties of the kringle 2 and protease domains are maintained in the refolded t-PA deletion variant BM 06.022. Protein Eng. 5:93-100.
13. LaVallie, E. R., and J. M. McCoy. 1995. Gene fusion expression systems in Escherichia coli. Curr. Opin. Biotechnol. 6:501-506.
14. Lee, I. Y., M. K. Kim, Y. H. Park, and S. Y. Lee. 1996. Regulatory effects of cellular nicotinamide nucleotides and enzyme activities on poly(3-hydroxybutyrate) synthesis in recombinant Escherichia coli. Biotechnol. Bioeng. 52: 707-712.
15. Manosroi, J., C. Tayapiwatana, F. Gotz, R. G. Werner, and A. Manosroi. 2001. Secretion of active recombinant human tissue plasminogen activator derivatives in Escherichia coli. Appl. Environ. Microbiol. 67:2657-2664.
16. Messens, J., and J. F. Collet. 2006. Pathways of disulfide bond formation in Escherichia coli. Int. J. Biochem. Cell Biol. 38:1050-1062.
17. Nordt, T. K., and C. Bode. 2003. Thrombolysis: Newer thrombolytic agents and their role in clinical medicine. Heart 89:1358-1362.
18. Obukowicz, M. G., M. E. Gustafson, K. D. Junger, R. M. Leimgruber, A. J. Wittwer, T. C. Wun, T. G. Warren, B. F. Bishop, K. J. Mathis, D. T. McPherson, et al. 1990. Secretion of active kringle-2-serine protease in Escherichia coli. Biochemistry 29:9737-9745.
19. Pennica, D., W. E. Holmes, W. J. Kohr, R. N. Harkins, G. A. Vehar, C. A. Ward, W. F. Bennett, E. Yelverton, P. H. Seeburg, H. L. Heyneker, D. V. Goeddel, and D. Collen. 1983. Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature 301:214-221. (Pubitemid 13142222)
20. Peters, V., and B. H. A. Rehm. 2006. In vivo enzyme immobilization by use of engineered polyhydroxyalkanoate synthase. Appl. Environ. Microbiol. 72:1777-1783.
21. Peters, V., and B. H. A. Rehm. 2005. In vivo monitoring of PHA granule formation using GFP-labeled PHA synthases. FEMS Microbiol. Lett. 248: 93-100.
22. Pötter, M., M. H. Madkour, F. Mayer, and A. Steinbüchel. 2002. Regulation of phasin expression and polyhydroxyalkanoate (PHA) granule formation in Ralstonia eutropha H16. Microbiology 148:2413-2426.
23. Pötter, M., and A. Steinbüchel. 2005. Poly(3-hydroxybutyrate) granule-associated proteins: Impacts on poly(3-hydroxybutyrate) synthesis and degradation. Biomacromolecules 6:552-560.
24. Rehm, B. H. A., and A. Steinbüchel. 1999. Biochemical and genetic analysis of PHA synthases and other proteins required for PHA synthesis. Int. J. Biol. Macromol. 25:3-19.
25. Schaffner, J., J. Winter, R. Rudolph, and E. Schwarz. 2001. Cosecretion of chaperones and low-molecular-size medium additives increases the yield of recombinant disulfide-bridged proteins. Appl. Environ. Microbiol. 67:3994-4000.
26. Smalling, R. W. 1997. Pharmacological and clinical impact of the unique molecular structure of a new plasminogen activator. Eur. Heart J. 18(suppl. F):F11-F16.
27. Wang, Z., H. Wu, J. Chen, J. Zhang, Y. Yao, and G. Q. Chen. 2008. A novel self-cleaving phasin tag for purification of recombinant proteins based on hydrophobic polyhydroxyalkanoate nanoparticles. Lab Chip 8:1957-1962.
28. Wooster, M. B., and A. B. Luzier. 1999. Reteplase: A new thrombolytic for the treatment of acute myocardial infarction. Ann. Pharmacother. 33:318-324.